2023 Could Be Big For Testosterone: AbbVie And ANI Best Positioned (ABBV) (ANIP)
jarun011 Introduction Results from three major testosterone related studies are due in 2023. They include cardiovascular (CV) safety and efficacy results in Testosterone Replacement Therapy (TRT) for both men and women. I expect an NDA […]
